Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Non-immune factors play a significant role in alopecia areata.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

MSCs should be called "master signaling cells" because they mainly help with cell communication and tissue repair.

A microneedle patch can help regrow hair by restoring immune balance in hair follicles.

Early diagnosis and treatment by vets are crucial for managing rare but severe feline skin disorders.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Childhood and adult height, and early immune-related hospitalizations increase testicular cancer risk, while baldness, larger families, and sports reduce it.

γδTregs may help treat autoimmune diseases like alopecia areata by promoting hair regrowth and reducing immune attacks.

A gel from stem cells can reduce baldness caused by fluconazole in rats.

Mesenchymal stem cell secretome shows promise for skin treatments but needs more human trials.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

3D spheroid cultures of human hair follicle cells are better for hair growth research than 2D cultures, and they provide new insights into how hair growth treatments like minoxidil and TCQA work.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Cellular senescence is crucial for normal embryonic development but contributes to aging in adults.

Vitiligo treatments include JAK inhibitors, UVB phototherapy, and dietary changes, with emotional support being important.

Children with alopecia areata have immune imbalances and are more likely to have certain health issues.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.